LEI 9598004RAJZ35WKFUQ20

FUNDACIÓ INSTITUT D'INVESTIGACIÓ BIOMÈDICA DE BELLVITGE

Awards tracked

39

Value

€7.67M

Countries

ES

Download sample CSV

Contract awards & public grants

Developing Immune Strategies to Counter tumor-immune-micrOnVironmEntal Resistance in NeuroEndocrine Tumors. → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2026-07-08

—

Addressing the role of self-organization in tumor heterogeneity and plasticity → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2025-02-26

€209,915

Fighting Addictions, improving Lives: COmprehensive drug rehabilitation with music → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2024-12-06

€486,131

Understanding vaccination hesitancy and evaluating single dose and gender-neutral vaccination for improving uptake of HPV vaccines in West and East Af → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2024-11-29

—

Multilevel approaches to understanding chronic inflammatory diseases. → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2024-08-29

—

Unleashing a CoMprehensive, Holistic and Patient Centric Stroke Management for a Better, Rapid, AdvancEd and PersonaLised Stroke Diagnosis, TreAtment → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2024-07-31

—

Framework to IMPROVE the Integration of Patient Generated Health Data to Facilitate Value Based Healthcare → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2023-11-10

€8,625

TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2023-04-24

—

Boosting Societal Adaptation and Mental Health in a Rapidly Digitalizing, Post-Pandemic Europe → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2023-04-21

—

Preventing lifetime obesity by early risk-factor identification, prognosis and intervention → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2023-04-11

—

Discovering the causes of three poorly understood cancers in Europe → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2022-12-06

—

Novel health care strategies for melanoma in children, adolescents and young adults → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2022-12-01

—

Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2022-05-30

—

The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2022-05-20

—

Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19 → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2021-11-12

—

Characterization of the gene and protein networks regulated by Staufen 2 in neurogenesis and their alterations in AD → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2021-04-20

€172,932

Polymeric cell-laden vascular graft for blood vessel mimicking in tissue engineering applications → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2021-04-12

€129,699

Pseudohypoxia-mediated cardiac regeneration → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2021-04-12

€160,932

Single cell tracking of malignant transformation in GATA2 deficiency → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2021-03-18

€160,932

Regeneration of Sinusoidal niches to preserve hematopoiesis after chemotherapy on Ageing → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2021-02-16

€2M

Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2021-01-29

—

Paths to Succesful Innovations → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2020-11-19

€22,963

A Human Neural Platform for Assaying Antigen-Antibody Interactions for Autoimmune Encephalitis → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2020-11-09

€150,000

Deconstructing the evolution of metastasis → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2020-09-03

—

Genetically modified organoids for genetic variant interpretation in colorectal cancer → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2020-04-06

€160,932

Role of the SWI/SNF complex in the Androgen Receptor cistrome regulation → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2020-03-11

€160,932

Human gut Microbiome, gene Expression and Colorectal Cancer: Assigning causal roles from a novel Mendelian randomization perspective. → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2018-04-05

€158,122

Identification of a novel function of lysosomes in mitosis for cancer therapy → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2018-03-19

€170,122

Personalized oncology for refractory and relapsed lymphoma using humanized patient derived othotopic xenografts (ImmunePDOX) → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2018-03-07

€170,122

DNA MEthylation for HPV-related disease among women living with HIV → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2018-03-06

€158,122

Targeting the metabolism-immune system connections in Cancer → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2017-08-10

€743,619

Activation of PI3K signalling in the pathogenesis of Vascular Anomalies → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2017-03-27

€158,122

Development of a ncRNA DNA Methylation Kit for Treatment Guidance in Cancer of Unknown Primary → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2016-10-10

€119,345

Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2016-07-26

€835,692

Identification and Characterization of Cis-Regulatory Module Dysfunction in Rett Syndrome with ROQ-WACh → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2016-02-29

€158,122

Endoplasmic Reticulum Stress in Health and Disease → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2015-08-18

€247,873

Deciphering PI3K biology in health and disease → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2015-08-07

€530,173

Development of a ncRNA DNA Methylation Kit for the Diagnosis of Cancer of Unknown Primary → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2015-02-02

€149,278

Chromatin Dynamics in Development and Disease → FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

European Commission · ES · Grant · 2014-12-12

€247,873

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.